What percentage of HD patients are affected by chorea?
Chorea affects about 90% of patients with HD at some stage in their illness3
Chorea may often be the first presenting symptom in HD6
The hallmark presentation of Huntington’s disease includes motor, cognitive, and psychiatric symptoms.2 The signs of chorea can be recognized in all stages of Huntington’s disease (HD).3
Chorea is typically assessed as part of the Unified Huntington’s Disease Rating Scale (UHDRS) – a valid and reliable research tool developed by the Huntington Study Group (HSG).4
Xenazine® (tetrabenazine) is indicated to treat chorea associated with HD; it does not treat cognitive or psychiatric symptoms.
XENAZINE® (tetrabenazine) Tablets
Indications and Usage:
XENAZINE is indicated for the treatment of chorea associated with Huntington’s disease.
Important Safety Information:
For more information, please see the full Prescribing Information, including Boxed Warning, the Medication Guide or go to www.XENAZINEusa.com.
Xenazine is a registered trademark of Valeant International Bermuda or its affiliates.
©2017 Lundbeck, Deerfield, IL 60015. All rights reserved.
The product information provided in this site is intended only for residents of the U.S. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.